Delivery Order SPE2DB20D3505-SPE2DB25FYCCP
- Not listed
- The Defense Logistics Agency awarded a $5,015.68 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This non-competitive, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,093.82 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This firm fixed price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,524.09 delivery order on July 29, 2025, for Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed-price, competitively awarded contract with performance in Conshohocken, Pennsylvania, and an ultimate completion date of July 30, 2025. The contract carries no set-aside designation. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $19,371.24 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). The award is non-competitive and utilizes firm fixed-price pricing, with an ultimate completion date of August 18, 2025. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical...
- The Defense Logistics Agency awarded a $11,045.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count units). The contract, which became effective on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $3,989.84 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $8,036.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a non-set-aside competitively awarded contract with performance completion scheduled for July 22, 2025, and fulfillment through AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a continuation of the company's pharmaceutical supply relationship with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,345.60 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $15,182.54 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCCPDelivery Order
The Defense Logistics Agency awarded a $1,508.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-unit package), with completion targeted for September 3, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product being delivered is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease, reflecting the Defense Logistics Agency's ongoing need to maintain pharmaceutical inventory supporting military healthcare systems and defense beneficiaries. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare networks. As a major healthcare solutions provider registered in the System for Award Management, the company maintains extensive federal contract relationships delivering a comprehensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic categories. This delivery order exemplifies the routine operational activity conducted under AmerisourceBergen's prime indefinite delivery contract framework, enabling flexible and expedited pharmaceutical sourcing to support defense healthcare requirements across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 9/2/25 |